LONDON / FRANKFURT: Pfizer and Biotech have agreed to provide their CoVID-19 vaccine to the World Health Organization-led CoVX vaccine distress scheme, two sources familiar with the deal said, adding that the latest in a series of shots is part of the project. Will be added. According to foreign media, low-income countries are the target.
According to sources, the agreement is likely to be announced on Friday, who declined to be named due to confidentiality of the agreement. Details about the size of the contract or the price per quake will not be immediately clear, but sources say the allotment will be relatively small. One source said the limited volume was due to the fact that the food was primarily for healthcare workers in the countries where CoAX provides services.
Biotech declined to comment, while Pfizer declined to comment. A spokesman for the WHO and GAVI Vaccine Alliance, which co-chairs the COVAX scheme, also declined to comment.
Bruce Aylward, a senior WHO adviser, said Monday that the Caucasus scheme is in “very detailed discussions” with Pfizer, which has compiled hundreds of millions of doses for several rich countries this year, and is expected to She could “add the vaccine to Cox.” Similarly”
The CoVAX scheme will begin distributing the COVID-19 vaccine in poor and middle-income countries in February. Ukraine had earlier said on Thursday that the first acquisition of the COVID-19 vaccine under the Caucasus scheme could take place in the first half of February – containing 210,000 doses of the Moderna, Pfizer or AstraZeneca vaccines.
Quix says it expects to deliver more than 2 billion quad 19 doses worldwide this year. In a latest forecast released on Thursday, it said it plans to provide about 1.8 billion dollars of food to 92 poor countries by 2021, about 27 percent of their population.
The scheme, led by the WHO, the GAVI Vaccine Alliance and the Coalition for Epidemic Preparation Innovations (CEPI), was launched last year amid fears that poorer countries would be wiped out while richer countries would vaccinate their populations. For this, they were forced to take the vaccine of covid 19. .
Cox, working at Oxford University, has so far received a future supply of vaccines from Australasia. Serum Institute of India (SII) with Sanofi and her partner GSK. It also includes a memorandum of understanding regarding the supply of Johnson and Johnson.
The Pfizer deal will be Coaster’s second, following an agreement with Stran Zenica, which covers regulatory-approved products in some countries. The additional commitment by Pfizer comes at a time when frustration is growing in European countries over unexpected cuts in supplies by US pharmaceuticals. Pfizer said last week that it would reduce supply by early February to improve production capacity to increase production later.
The Pfizer and Biotech Covid 19 vaccine has so far been the only shot to be approved by the WHO Emergency Use List.